WellTheory
Personalized autoimmune nutrition coaching
Channel Partnerships Manager
+ Bonus + Equity
Travel required 10–20% of the time, including in-person partner meetings.
About the job
- Have 7–12+ years of experience in channel partnerships, partner management, or business development in digital health, benefits technology, or health plan/PBM adjacencies, including activating partnerships from initial conversation through negotiation, contracting, co-selling setup, and first revenue.
- Have experience building a category and educating the market about new models of care.
- Demonstrate strong verbal and written communication, presentation skills, storytelling ability, and the ability to craft emails, proposals, and partner-facing materials.
- Use a consultative approach to uncover partner needs and guide partners toward new perspectives.
- Collaborate effectively with internal and external stakeholders, build feedback loops with sales teams, make referrals actionable, and create mutual accountability.
- Qualify partnership opportunities realistically and maintain a pipeline grounded in likely outcomes.
- Be willing to travel 10–20% of the time.
- Be proactive, resourceful, comfortable with ambiguity, and willing to make judgment calls without a predefined roadmap.
- Maintain an up-to-date customer relationship management system and document deal progress and written context clearly.
- Demonstrate empathy for the lived experience of autoimmune patients and convey that perspective effectively to potential partners.
- Activate in-flight channel partnerships from signed contract through the first joint deal and steady-state co-selling.
- Build co-selling infrastructure, including joint pipeline reviews, opportunity assessment processes, and partner-facing playbooks.
- Manage ongoing partner relationships, meeting cadences, executive relationships, and escalations.
- Drive new channel partnership negotiations from initial conversation through contracting.
- Partner with account executives and Sales Operations to route, track, and follow up on channel-sourced leads in Salesforce.
- Represent WellTheory independently in executive-level partner conversations by running meetings, presenting the company model, and building credibility with senior health plan and pharmacy benefit manager stakeholders.
- Operationalize upcoming partner launches and build the partnership playbook.
- Existing relationships with health plan, pharmacy benefit manager, or care navigation channel partners.
- Experience with sales at a best-in-class digital health company.
About the company
WellTheory provides personalized nutrition and lifestyle coaching for people with autoimmune conditions. Subscriptions give access to long-term, evolving care plans with in-depth one-on-one video sessions and unlimited messaging from a care team that includes people with lived autoimmune experience. In addition to coaching, it sells dietary supplements to support symptom management and offers a supportive community. The goal is to help clients manage autoimmune symptoms and improve quality of life through evidence-based guidance and ongoing, tailored care.
Company Size
51-200
Company Stage
Series A
Total Funding
$26.2M
Headquarters
Atherton, California
Founded
2020
Get referred to WellTheory
See people who can refer or advise you
Simplify's Take
What believers are saying
- March 2026 survey with Autoimmune Association sharpened WellTheory's employer-sales narrative.
- September 2026 Judi Health partnership expands reach to plan sponsors immediately.
- 2025–2026 funding and 10x membership growth show strong demand and investor confidence.
What critics are saying
- Category giants like Judi Health now distribute WellTheory alongside competing clinical point solutions.
- Autoimmune outcomes claims depend on narrow employer contracts; one lost renews revenue immediately.
- If AI personalization disappoints, employers will cut pilots after 2026 procurement cycles.
What makes WellTheory unique
- Built by autoimmune patients, with licensed dietitians and coaches specializing in 100 conditions.
- Care Hub and Care Scribe personalize longitudinal support using member labs, symptoms, and interventions.
- Enterprise solution embeds autoimmune care into employer and payer benefits, not standalone consumer wellness.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Company Equity
Flexible Work Hours
Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Home Office Stipend
Professional Development Budget
Paid Holidays
Company Social Events
Growth & Insights and Company News
6 month growth
↑ 4%1 year growth
↓ -1%2 year growth
↓ -5%Judi Health taps Color Health, WellTheory, Cylinder for clinical ecosystem. Judi Health expanded its healthcare network to offer specialized virtual care for cancer, autoimmune and GI conditions while helping employers reduce overall healthcare costs. Judi Health, a health technology company and benefits administrator, announced Thursday that it has expanded its clinical ecosystem to include Color Health, WellTheory and Cylinder. New York-based Judi Health, previously known as Capital Rx, offers solutions for employers, unions, health plans and government entities. Its Unified Claims Processing solution supports programs for pharmacy, medical, vision and dental benefits and allows plan sponsors to add condition-specific support. Judi Health's clinical ecosystem offers access to specialized, condition-specific programs that customers can choose from. Through the clinical ecosystem, Color Health will offer access to cancer care through its virtual ASCO-certified clinic. WellTheory will provide virtual care for more than 100 autoimmune and inflammatory conditions, while Cylinder will offer on-demand gastrointestinal care. Cylinder was recently acquired by virtual musculoskeletal provider Hinge Health. presented by Healthcare payments are no longer about transactions. It's about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs. "When selecting partners, we look for conditions like cancer, autoimmune disease, and GI where medical and pharmacy spending are deeply interconnected, because that's the only place the full cost of care becomes visible," said Sara Izadi, chief clinical officer at Judi Health, in an email. "These are areas where pharmacy data alone provides an incomplete picture of both the patient experience and the true cost of care. WellTheory, Cylinder, and Color were selected because they bring deep expertise in these complex conditions and align with our vision of connected, whole-person care." These companies have achieved meaningful results, according to the announcement. Color Health has been shown to increase cancer screening rates by up to 77%, and more than 85% of Cylinder members report symptom improvement within 90 days. WellTheory has achieved 64% fewer emergency room visits among its members. Existing clinical ecosystem partners include Sword Health for virtual musculoskeletal care and Progyny for fertility, maternity and menopause services. The announcement comes as employers anticipate that healthcare cost trends will increase by a median 9.2% in 2027, according to a recent survey from the Business Group on Health. Many employers are turning to virtual health solutions to control costs, but managing multiple vendors can be a challenge. presented by In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable. "Our goal is to lower the total cost of care, not shift it from one bucket to another," Izadi said. "With these partnerships, we're trying to do two things: get ahead of progression, for example, by supporting an autoimmune patient with lower-acuity interventions before they need a biologic, and for patients who do progress, measure the total cost of care and the outcome rather than citing a theoretical savings number for avoided ER visits."
New survey: 70% of women with an autoimmune condition say it's limited their career potential. Its study, conducted in partnership with the Autoimmune Association, shines light on the hidden costs of chronic illness for women and their employers. 80% of individuals diagnosed with autoimmune diseases are women - and for many, their condition impacts not just their health, but their career trajectory. WellTheory Technologies, Inc. partnered with the Autoimmune Association to conduct a national survey of 250 U.S. working women with autoimmune diseases. The findings, released during Autoimmune Awareness Month, reveal how autoimmune disease is quietly reshaping the workplace - and the urgent need for care models that better support those with chronic conditions. Stalled careers, lost potential. 70% of working women with an autoimmune condition say that their career potential has suffered, and 68% report they've experienced negative effects at work since being diagnosed. Among these women: These numbers highlight the difficult decisions many women face when balancing the demands of a job and a chronic condition - and how the trade-offs can impact their careers long-term. Women are carrying an invisible burden. Autoimmune symptoms can take a toll on women's day-to-day lives, with 61% saying that their symptoms impact their ability to function at work every day or most days. They're living with symptoms like chronic pain, fatigue, and brain fog, yet 61% have chosen not to disclose their autoimmune condition to their employer. Fear of being judged (32%), concern about being passed over for opportunities (28%), or simply believing that telling their employer about their condition won't help (41%) are keeping women silent - and keeping employers in the dark. Managing a chronic health condition comes with a cost. For many women with autoimmune diseases, career decisions aren't just about growth - they're about survival. 68% have stayed at a job because they needed health insurance, and 76% reported experiencing financial strain due to their condition. But autoimmune conditions cost employers, too - contributing to employee absenteeism, reduced productivity, and driving 50% of specialty drug spend. With autoimmune diagnoses on the rise, it's becoming increasingly important to address chronic care models across the workforce. Women shouldn't have to choose between their career and their health. Autoimmune diseases require personalized care, yet many women are left navigating fragmented systems that prioritize short-term symptom management over long-term results. "When women receive consistent, specialized autoimmune care, they don't have to sacrifice their careers for their health," says Ellen Rudolph, CEO and Co-Founder of WellTheory. "We work alongside employers to provide that support, helping women manage chronic symptoms while staying on their chosen professional paths." Its evidence-based care model provides members with ongoing clinical guidance and personalized support to help reduce symptom disruptions at work. Outcomes show improvements in physical and mental health, workplace productivity, and lower costs - proof that when women with autoimmune conditions get the support they need, everyone benefits.
WellTheory, a virtual care platform for autoimmune disease, has launched a Postpartum Program to support women experiencing autoimmune symptoms after childbirth. The programme addresses a critical gap, as traditional postpartum care typically ends within weeks of delivery despite hormonal changes continuing for months. Autoimmune disease affects over 50 million Americans, with 80% being women. Pregnancy and childbirth are common triggers for new diagnoses or symptom flare-ups due to significant hormonal shifts. The programme offers personalised care plans, one-on-one support from autoimmune and hormonal health experts, and advanced hormonal testing. It follows WellTheory's earlier Hormonal Health Program and targets an employer priority: supporting women returning to work during the postpartum period when symptoms often persist but healthcare support has ended.
WellTheory Technologies, Inc. just raised a $14M Series A led by General Catalyst. Here's what's next for autoimmune care. WellTheory raised $14M in Series A funding led by General Catalyst to expand its personalized, women-led approach to reimagining autoimmune care for millions of patients. Today marks a new chapter for WellTheory - and for the millions of Americans living with autoimmune disease. WellTheory Technologies, Inc. is proud to announce its $14M Series A funding led by General Catalyst, with participation from 7wire Ventures, Ingeborg Investments, Accel, Box Group, and Up2 Opportunity Fund. This milestone means so much more than funding. It's proof that the world is starting to pay attention to an epidemic that's been ignored for far too long. The growing autoimmune crisis. Autoimmune disease affects over 50 million Americans, 80% of whom are women. Yet for decades, it's been misunderstood, underdiagnosed, and overlooked. These conditions are rising faster than any other disease category, doubling in prevalence in just 30 years. The costs are staggering. Autoimmune disease now represents a $150B+ annual market, a figure that continues to climb as new immunology drugs come to market. These conditions account for 50% of all specialty drug spend, which has risen 459% over the past decade. Employers and health plans feel this burden acutely, but autoimmune diseases are often invisible in claims data - scattered across specialties, never tied back to the same root cause. Behind those numbers are real people. People who have spent years searching for answers, only to be told their labs look "normal" or that their symptoms are "all in their head." From personal stories to a shared mission. At 25, I was bedridden and desperate for answers. I spent months cycling through specialists and tests, hoping someone would finally connect the dots. When I was eventually diagnosed with an autoimmune condition, I realized just how broken the system was and how many others were being left behind. Along the way, I connected with my co-founders, Claire and Wallace, whose lives had also been touched by autoimmune disease. Together, WellTheory Technologies, Inc. decided to build the solution WellTheory Technologies, Inc. all wished had existed at the start of its journeys - care that's personalized, proactive, and rooted in compassion. When WellTheory Technologies, Inc. launched WellTheory, its goal was simple but ambitious: to reimagine autoimmune care from the ground up with a model that looks at the whole person, not just the diagnosis. What started as a small, passionate community has grown into something much larger. Today, WellTheory Technologies, Inc. is seeing thousands of members reduce symptoms, regain energy, and rebuild their lives after years of being dismissed. Employers and health plans are also recognizing what patients have known all along: autoimmune conditions can't be treated in silos. They're now turning to WellTheory to address autoimmune conditions at scale - not as isolated diseases, but as systemic issues affecting every aspect of well-being and productivity. Built & backed by women: defying the odds. As a woman living with autoimmune disease, I've spent years navigating systems that weren't built for patients like me - or founders like me, either. Less than 2% of venture capital goes to women. Only 17% of VC decision-makers are women. And women's health continues to be chronically underfunded. That's why this round feels especially meaningful and why I couldn't be prouder that its cap table reflects the patients WellTheory Technologies, Inc. serve. When I met Candace and Holly from General Catalyst, I knew I'd found partners who truly understood. Both had personal connections to autoimmune disease - they'd seen the toll it takes on people they love. They believed in this mission not just as investors, but as women who have seen the system fail people they love and who want to change it. I'm also grateful to have Alyssa and Tiffany from 7wire Ventures and Anna and Mira from Ingeborg Investments joining this mission - women who share its conviction that health equity and access go hand in hand. Together, WellTheory Technologies, Inc. is showing what happens when women build, back, and lead in healthcare, and it feels like WellTheory Technologies, Inc. is building the system WellTheory Technologies, Inc. has always deserved to see. What's ahead. In just the last year, WellTheory has grown more than 10x in membership and partnered with visionary employers and payors like Fortune Brands, Dayforce, and Sentara Health Plans. WellTheory Technologies, Inc. has built proprietary AI tools - Care Hub and Care Scribe - to help its care teams personalize support and improve health outcomes at scale. * Deepen partnerships with employers and health plans * Expand its care programs to reach more people and conditions * Accelerate AI development to make its care even more personalized and accessible WellTheory Technologies, Inc. is investing in technology, clinical research, and enterprise expansion to bring this model to millions - because addressing autoimmune disease isn't just about managing symptoms; it's about redefining what care can look like. P.S. WellTheory Technologies, Inc. is growing fast and hiring across teams. If you feel called to its mission and driven by grit, resilience, and a belief that change happens when people refuse to accept the status quo - WellTheory Technologies, Inc.'d love to meet you.
Instacart and WellTheory announce partnership to improve nutrition access for autoimmune patients. ByDr. Sai Balasubramanian, M.D., J.D., Contributor. Sai writes about healthcare, innovation and technology. Today, WellTheory, a care platform for individuals with autoimmune disease, announced a partnership with delivery provider Instacart to address inequities in access to anti-inflammatory and nutritious food. The newly formed partnership will integrate Instacart Health's Fresh Funds program with WellTheory's platform, providing patients with an opportunity to leverage the grocery delivery giant's technology to purchase recommended food to improve their health. Last month, WellTheory announced that it raised $14 million as a part of a Series A round led by VC giant General Catalyst. The platform aims to provide holistic and longitudinal care for patients with autoimmune disease by working with employer based plans, but also provides individuals support through the platform for 1:1 dietitian consults, personalized care and success plans, easy-to-access appointments, and a variety of testing to understand and treat symptoms. In working with employers, the company indicates that it can provide upto $9400 in savings per member, per year, with a 64% reduction in emergency room visit costs and with 91% of patients reporting relief. Now, with access to Instacart's program, nearly 300,000 patients in WellTheory's network will be able to access grocery stipends to purchase clinically recommended foods directly through Instacart, ensuring accessibility, convenience and health. Furthermore, given Instacart's widespread reach throughout the US, this program will benefit people across communities of all sizes and locations. Claire Rudolph, co-founder and head of product at WellTheory, explains that food is one of the most important aspects of the autoimmune journey, and the goal with this partnership is to decrease as much friction as possible in providing people with the nutrition they need. Sarah Mastrorocco, vice president and general manager of health at Instacart, agreed with this sentiment, commenting that Instacart's mission is to improve access to timely groceries and foster convenience for communities. With the integration of these two organizations, hundreds of thousands of people will benefit. Because the prevalence of autoimmune disease is rising. Per an article by Molly Murray, president and CEO of the Autoimmune Association, "The rising prevalence of autoimmune disease is a concerning trend that underscores the urgent need for increased advocacy, awareness, education, and research." Murray also discusses that autoimmune diseases often do not have cures, meaning that patients have to manage lifestyle factors, such as environmental exposures and diet, incredibly strictly. In fact, many studies have indicated that diets are a central aspect of triggering autoimmune conditions in individuals and that nutrition management is one of the key means by which conditions can be managed. Generally speaking, given the increasing rates of autoimmune conditions, more companies have emerged that are trying to address this patient population. For example, kyverna is a pharmaceutical company that is developing cell therapies specifically for patients with autoimmune conditions. Attune Health is another that is focusing on autoimmune care and research. Healthcare organizations are also realizing that these patients require more tailored care than the general population; hence, many are investing in specialty clinics, such as for rheumatology, with dedicated staff to address disease-specific needs. The work in this space is just getting started. With nearly 15 million people impacted by autoimmune diseases in the US alone, more awareness, resources and research are imperative for this area.